Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: Involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling

Ting Wang, Youxue Wang, Yasuhide Kontani, Yoshinori Kobayashi, Yuzo Sato, Nozomu Mori, Hitoshi Yamashita

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Evodiamine is an alkaloidal compound with antiobesity effects that have been thought to be due to uncoupling protein-1 (UCP1) thermogenesis similar to the effects of capsaicin, but the underlying mechanisms are poorly understood. To clarify the mechanisms, we first examined whether the antiobesity effect of evodiamine could be attributed to the involvement of UCP1. When UCP1-knockout mice were fed a high-fat diet with 0.03% evodiamine (wt/wt) for 2 months, the increases in body weight, adiposity, and the serum levels of leptin and insulin were reduced in a manner indistinguishable from control mice fed a high-fat diet with evodiamine, suggesting that evodiamine triggered a UCP1-independent mechanism to prevent diet-induced obesity. By using preadipocyte cultures, we found that evodiamine, but not capsaicin, increased phosphorylation of ERK/MAPK, reduced the expression of transcription factors such as peroxisome proliferator-activated receptor-γ, and strongly inhibited adipocyte differentiation. Evodiamine treatment also reduced insulin-stimulated phosphorylation of Akt, a crucial regulator of adipocyte differentiation; and the reduction of phosphorylated-Akt and augmentation of phosphorylated ERK were reversed by blockade of the MAPK kinase/MAPK signaling pathway, restoring adipogenesis in the cultures. The changes in ERK and Akt phosphorylation levels were also observed in white adipose tissues of UCP1-knockout mice fed the evodiamine diet. These findings suggest that evodiamine has a potential to prevent the development of diet-induced obesity in part by inhibiting adipocyte differentiation through ERK activation and its negative cross talk with the insulin signaling pathway.

Original languageEnglish (US)
Pages (from-to)358-366
Number of pages9
JournalEndocrinology
Volume149
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Mitogen-Activated Protein Kinases
Phosphotransferases
Obesity
Diet
Adipocytes
Capsaicin
Phosphorylation
High Fat Diet
Insulin
Knockout Mice
evodiamine
Uncoupling Protein 1
Adipogenesis
White Adipose Tissue
Peroxisome Proliferator-Activated Receptors
Thermogenesis
Mitogen-Activated Protein Kinase Kinases
Adiposity
Leptin
Transcription Factors

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner : Involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling. / Wang, Ting; Wang, Youxue; Kontani, Yasuhide; Kobayashi, Yoshinori; Sato, Yuzo; Mori, Nozomu; Yamashita, Hitoshi.

In: Endocrinology, Vol. 149, No. 1, 01.2008, p. 358-366.

Research output: Contribution to journalArticle

Wang, Ting ; Wang, Youxue ; Kontani, Yasuhide ; Kobayashi, Yoshinori ; Sato, Yuzo ; Mori, Nozomu ; Yamashita, Hitoshi. / Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner : Involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling. In: Endocrinology. 2008 ; Vol. 149, No. 1. pp. 358-366.
@article{e7804b192fec47ccb498fc959f0b0eaf,
title = "Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: Involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling",
abstract = "Evodiamine is an alkaloidal compound with antiobesity effects that have been thought to be due to uncoupling protein-1 (UCP1) thermogenesis similar to the effects of capsaicin, but the underlying mechanisms are poorly understood. To clarify the mechanisms, we first examined whether the antiobesity effect of evodiamine could be attributed to the involvement of UCP1. When UCP1-knockout mice were fed a high-fat diet with 0.03{\%} evodiamine (wt/wt) for 2 months, the increases in body weight, adiposity, and the serum levels of leptin and insulin were reduced in a manner indistinguishable from control mice fed a high-fat diet with evodiamine, suggesting that evodiamine triggered a UCP1-independent mechanism to prevent diet-induced obesity. By using preadipocyte cultures, we found that evodiamine, but not capsaicin, increased phosphorylation of ERK/MAPK, reduced the expression of transcription factors such as peroxisome proliferator-activated receptor-γ, and strongly inhibited adipocyte differentiation. Evodiamine treatment also reduced insulin-stimulated phosphorylation of Akt, a crucial regulator of adipocyte differentiation; and the reduction of phosphorylated-Akt and augmentation of phosphorylated ERK were reversed by blockade of the MAPK kinase/MAPK signaling pathway, restoring adipogenesis in the cultures. The changes in ERK and Akt phosphorylation levels were also observed in white adipose tissues of UCP1-knockout mice fed the evodiamine diet. These findings suggest that evodiamine has a potential to prevent the development of diet-induced obesity in part by inhibiting adipocyte differentiation through ERK activation and its negative cross talk with the insulin signaling pathway.",
author = "Ting Wang and Youxue Wang and Yasuhide Kontani and Yoshinori Kobayashi and Yuzo Sato and Nozomu Mori and Hitoshi Yamashita",
year = "2008",
month = "1",
doi = "10.1210/en.2007-0467",
language = "English (US)",
volume = "149",
pages = "358--366",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner

T2 - Involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling

AU - Wang, Ting

AU - Wang, Youxue

AU - Kontani, Yasuhide

AU - Kobayashi, Yoshinori

AU - Sato, Yuzo

AU - Mori, Nozomu

AU - Yamashita, Hitoshi

PY - 2008/1

Y1 - 2008/1

N2 - Evodiamine is an alkaloidal compound with antiobesity effects that have been thought to be due to uncoupling protein-1 (UCP1) thermogenesis similar to the effects of capsaicin, but the underlying mechanisms are poorly understood. To clarify the mechanisms, we first examined whether the antiobesity effect of evodiamine could be attributed to the involvement of UCP1. When UCP1-knockout mice were fed a high-fat diet with 0.03% evodiamine (wt/wt) for 2 months, the increases in body weight, adiposity, and the serum levels of leptin and insulin were reduced in a manner indistinguishable from control mice fed a high-fat diet with evodiamine, suggesting that evodiamine triggered a UCP1-independent mechanism to prevent diet-induced obesity. By using preadipocyte cultures, we found that evodiamine, but not capsaicin, increased phosphorylation of ERK/MAPK, reduced the expression of transcription factors such as peroxisome proliferator-activated receptor-γ, and strongly inhibited adipocyte differentiation. Evodiamine treatment also reduced insulin-stimulated phosphorylation of Akt, a crucial regulator of adipocyte differentiation; and the reduction of phosphorylated-Akt and augmentation of phosphorylated ERK were reversed by blockade of the MAPK kinase/MAPK signaling pathway, restoring adipogenesis in the cultures. The changes in ERK and Akt phosphorylation levels were also observed in white adipose tissues of UCP1-knockout mice fed the evodiamine diet. These findings suggest that evodiamine has a potential to prevent the development of diet-induced obesity in part by inhibiting adipocyte differentiation through ERK activation and its negative cross talk with the insulin signaling pathway.

AB - Evodiamine is an alkaloidal compound with antiobesity effects that have been thought to be due to uncoupling protein-1 (UCP1) thermogenesis similar to the effects of capsaicin, but the underlying mechanisms are poorly understood. To clarify the mechanisms, we first examined whether the antiobesity effect of evodiamine could be attributed to the involvement of UCP1. When UCP1-knockout mice were fed a high-fat diet with 0.03% evodiamine (wt/wt) for 2 months, the increases in body weight, adiposity, and the serum levels of leptin and insulin were reduced in a manner indistinguishable from control mice fed a high-fat diet with evodiamine, suggesting that evodiamine triggered a UCP1-independent mechanism to prevent diet-induced obesity. By using preadipocyte cultures, we found that evodiamine, but not capsaicin, increased phosphorylation of ERK/MAPK, reduced the expression of transcription factors such as peroxisome proliferator-activated receptor-γ, and strongly inhibited adipocyte differentiation. Evodiamine treatment also reduced insulin-stimulated phosphorylation of Akt, a crucial regulator of adipocyte differentiation; and the reduction of phosphorylated-Akt and augmentation of phosphorylated ERK were reversed by blockade of the MAPK kinase/MAPK signaling pathway, restoring adipogenesis in the cultures. The changes in ERK and Akt phosphorylation levels were also observed in white adipose tissues of UCP1-knockout mice fed the evodiamine diet. These findings suggest that evodiamine has a potential to prevent the development of diet-induced obesity in part by inhibiting adipocyte differentiation through ERK activation and its negative cross talk with the insulin signaling pathway.

UR - http://www.scopus.com/inward/record.url?scp=37549014582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549014582&partnerID=8YFLogxK

U2 - 10.1210/en.2007-0467

DO - 10.1210/en.2007-0467

M3 - Article

C2 - 17884939

AN - SCOPUS:37549014582

VL - 149

SP - 358

EP - 366

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 1

ER -